Ryan Specialty (NYSE: RYAN) grants CEO 168,577 options at $29.66

Q: What insider transaction did RYAN report for Timothy William Turner?

Ryan Specialty reported that CEO and director Timothy William Turner received a grant of 168,577 Executive Chairman stock options . These options are a form of equity compensation , giving him the right to buy Class A common shares at a fixed exercise price.

Q: What is the exercise price of the new RYAN stock options?

The granted options carry an exercise price of $29.66 per share . This means Turner can purchase Class A common stock at $29.66 for each option exercised, regardless of the market price when he chooses to exercise, subject to vesting and expiration.

Q: When do Timothy Turner’s new RYAN options vest?

The options vest in three equal installments on July 1, 2029 , July 1, 2030 , and July 1, 2031 . Vesting means Turner earns the right to exercise portions of the 168,577 options progressively over these future dates.

Q: What is the expiration date of the RYAN stock options granted to the CEO?

The stock options granted to Turner expire on May 5, 2036 . After that date, any unexercised options become worthless. Until expiry, vested options can be exercised 1-for-1 into Class A common stock at the fixed $29.66 exercise price.

Q: How many shares of RYAN Class A stock can these options convert into?

The options are exercisable on a 1-for-1 basis into Class A common stock , covering 168,577 underlying shares . Each vested option, if exercised before expiration, converts into one share of Ryan Specialty’s Class A common stock at the set exercise price.

Q: Who approved the stock option grant reported by RYAN?

The option grant was approved by the board’s compensation and governance committee . The approval was made for purposes of Rule 16(b)(3) , which provides an exemption from certain short-swing profit recovery rules when insider awards are properly authorized.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ryan Specialty Holdings, Inc. director and Chief Executive Officer Timothy William Turner received a grant of 168,577 Executive Chairman stock options. The options have an exercise price of $29.66 per share, expire on May 5, 2036, and are exercisable on a 1-for-1 basis into Class A common stock. They vest in equal installments on July 1, 2029, July 1, 2030, and July 1, 2031, and were approved by the board’s compensation and governance committee.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider TURNER TIMOTHY WILLIAM

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Executive Chairman Stock Option	168,577	$0.00	--

Holdings After Transaction: Executive Chairman Stock Option — 168,577 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 168,577 options Exercise price: $29.66 per share Underlying shares: 168,577 shares +5 more

8 metrics

Option grant size 168,577 options Executive Chairman Stock Option award to CEO Turner

Exercise price $29.66 per share Exercise price for Executive Chairman Stock Option

Underlying shares 168,577 shares Class A common stock underlying the options

Expiration date May 5, 2036 Option expiration for Executive Chairman grant

Post-transaction option holdings 168,577 options Total Executive Chairman options following this grant

First vesting date July 1, 2029 First of three equal vesting installments

Second vesting date July 1, 2030 Second of three equal vesting installments

Third vesting date July 1, 2031 Final vesting installment for the grant

Key Terms

Executive Chairman Stock Option, Class A common stock, Rule 16(b)(3), exercise price

4 terms

Executive Chairman Stock Option financial

"security_title: "Executive Chairman Stock Option""

Class A common stock financial

"exercisable on a 1-for-1 basis for shares of Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Rule 16(b)(3) regulatory

"grant was approved by the compensation and governance committee ... for the purposes of rule 16(b)(3)"

exercise price financial

"conversion_or_exercise_price: "29.6600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

05/06/2026 - 05:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TURNER TIMOTHY WILLIAM

(Last)

(First)

(Middle)

155 NORTH WACKER DRIVE, SUITE 4000

(Street)

CHICAGO

ILLINOIS

60606

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RYAN SPECIALTY HOLDINGS, INC. [ RYAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Executive Chairman Stock Option	$29.66	05/05/2026		A		168,577		⁽¹⁾	05/05/2036	Class A Common Stock	168,577	$0	168,577	D

Explanation of Responses:

1. The stock options vest in equal amounts on July 1, 2029, 2030 and 2031 and are exercisable on a 1-for-1 basis for shares of Class A common stock, par value $0.001 per share, of the Issuer. Such grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).

Remarks:

	/s/ Mark S. Katz, as Attorney-in-Fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did RYAN report for Timothy William Turner?

Ryan Specialty reported that CEO and director Timothy William Turner received a grant of 168,577 Executive Chairman stock options. These options are a form of equity compensation, giving him the right to buy Class A common shares at a fixed exercise price.

What is the exercise price of the new RYAN stock options?

The granted options carry an exercise price of $29.66 per share. This means Turner can purchase Class A common stock at $29.66 for each option exercised, regardless of the market price when he chooses to exercise, subject to vesting and expiration.

When do Timothy Turner’s new RYAN options vest?

The options vest in three equal installments on July 1, 2029, July 1, 2030, and July 1, 2031. Vesting means Turner earns the right to exercise portions of the 168,577 options progressively over these future dates.

What is the expiration date of the RYAN stock options granted to the CEO?

The stock options granted to Turner expire on May 5, 2036. After that date, any unexercised options become worthless. Until expiry, vested options can be exercised 1-for-1 into Class A common stock at the fixed $29.66 exercise price.

How many shares of RYAN Class A stock can these options convert into?

The options are exercisable on a 1-for-1 basis into Class A common stock, covering 168,577 underlying shares. Each vested option, if exercised before expiration, converts into one share of Ryan Specialty’s Class A common stock at the set exercise price.

Who approved the stock option grant reported by RYAN?

The option grant was approved by the board’s compensation and governance committee. The approval was made for purposes of Rule 16(b)(3), which provides an exemption from certain short-swing profit recovery rules when insider awards are properly authorized.